CJC-1295 w/o DAC 5 + IPA 5

Description

CJC-1295 w/o DAC 5 and IPA 5 are synthetic peptides used in research to explore their effects on growth hormone (GH) regulation, metabolic function, and tissue regeneration. CJC-1295 without DAC (Drug Affinity Complex) is a modified version of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone in a pulsatile manner, without the prolonged release provided by the DAC variant. IPA 5, a peptide with unique properties, is used to study its potential role in modulating the effects of growth hormone and supporting metabolic regulation.

CJC-1295 w/o DAC 5 works by binding to the GHRH receptor, promoting the release of GH, which stimulates the production of insulin-like growth factor 1 (IGF-1). This peptide is ideal for studies that require a controlled, pulse-like release of GH, making it a valuable tool in research on muscle regeneration, fat metabolism, and growth hormone deficiencies. It has been used in studies related to aging, muscle regeneration, and metabolic disorders.

IPA 5 plays a complementary role by modulating specific metabolic pathways, supporting the effects of CJC-1295 on fat loss, muscle growth, and energy balance. IPA 5 is often researched for its potential to enhance the efficacy of growth hormone treatments, making it an important peptide for combined studies on tissue repair, metabolic regulation, and performance enhancement.

The 10mg vial of CJC-1295 w/o DAC 5 + IPA 5 is ideal for researchers beginning investigations into growth hormone regulation, metabolic health, and tissue regeneration. This vial size is suitable for in vitro receptor assays, cell-based studies, and early in vivo experiments in animal models, providing enough material for focused research without requiring larger quantities.

Progression Peptides offers CJC-1295 w/o DAC 5 + IPA 5 as high-purity lyophilized powders with third-party purity verification, ensuring the peptides meet rigorous standards for consistent and reliable research. The lyophilized form preserves the stability and bioactivity of the peptides when handled and stored correctly.

Reconstitution: Reconstitute with bacteriostatic water, allowing it to dissolve gently without agitation. The solution should remain clear and free from visible particles.

Storage: Store the lyophilized peptides at -20°C. Once reconstituted, refrigerate at 2-8°C and use within 30 days.

For research purposes only. Not for human consumption or veterinary use. Sold exclusively for laboratory and in vitro research.